Q BioMed Inc. reported that its second quarter revenues in 2022 are up over 100% from its first quarter revenues and up over 300% from the second quarter of 2021, representing the best quarter result for sales despite market conditions that the Company believes are making additional investment into the sales effort challenging.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | 0.00% | -50.00% |
2023 | Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023 | CI |
2023 | Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 29.02K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- QBIO Stock
- News Q BioMed Inc.
- Q BioMed Inc. Reports Second Quarter Revenues in 2022